Michael Kloss, eureKing CEO
Manufacturing-centric SPAC makes a deal to combine with French CDMO
As smaller biotechs outfits are looking to go public, the special purpose acquisition company, or SPAC, space has been quite an attractive alternative. Most recently …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.